Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

RR vs IRBT vs ISRG vs NVDA vs NVCR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
RR
Richtech Robotics Inc. Class B Common Stock

Industrial - Machinery

IndustrialsNASDAQ • US
Market Cap$460M
5Y Perf.-38.2%
IRBT
iRobot Corporation

Furnishings, Fixtures & Appliances

Consumer CyclicalNASDAQ • US
Market Cap$2M
5Y Perf.-99.9%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$159.85B
5Y Perf.+44.8%
NVDA
NVIDIA Corporation

Semiconductors

TechnologyNASDAQ • US
Market Cap$5.23T
5Y Perf.+360.2%
NVCR
NovoCure Limited

Medical - Instruments & Supplies

HealthcareNASDAQ • JE
Market Cap$2.04B
5Y Perf.+45.8%

RR vs IRBT vs ISRG vs NVDA vs NVCR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
RR logoRR
IRBT logoIRBT
ISRG logoISRG
NVDA logoNVDA
NVCR logoNVCR
IndustryIndustrial - MachineryFurnishings, Fixtures & AppliancesMedical - Instruments & SuppliesSemiconductorsMedical - Instruments & Supplies
Market Cap$460M$2M$159.85B$5.23T$2.04B
Revenue (TTM)$5M$547M$10.58B$215.94B$674M
Net Income (TTM)$-12M$-209M$2.98B$120.07B$-173M
Gross Margin55.8%22.0%66.3%71.1%75.2%
Operating Margin-5.2%-29.5%30.5%60.4%-27.2%
Forward P/E43.3x26.0x
Total Debt$730K$227M$303M$11.41B$290M
Cash & Equiv.$194M$134M$3.37B$10.61B$103M

RR vs IRBT vs ISRG vs NVDA vs NVCRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

RR
IRBT
ISRG
NVDA
NVCR
StockNov 23May 26Return
Richtech Robotics I… (RR)10061.8-38.2%
iRobot Corporation (IRBT)1000.1-99.9%
Intuitive Surgical,… (ISRG)100144.8+44.8%
NVIDIA Corporation (NVDA)100460.2+360.2%
NovoCure Limited (NVCR)100145.8+45.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: RR vs IRBT vs ISRG vs NVDA vs NVCR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NVDA leads in 6 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Intuitive Surgical, Inc. is the stronger pick specifically for capital preservation and lower volatility. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
RR
Richtech Robotics Inc. Class B Common Stock
The Industrials Pick

RR plays a supporting role in this comparison — it may shine differently against other peers.

Best for: industrials exposure
IRBT
iRobot Corporation
The Consumer Cyclical Pick

IRBT lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: consumer cyclical exposure
ISRG
Intuitive Surgical, Inc.
The Income Pick

ISRG is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.

  • beta 1.00
  • Lower volatility, beta 1.00, Low D/E 1.7%, current ratio 4.87x
  • Beta 1.00, current ratio 4.87x
  • Beta 1.00 vs IRBT's 5.31, lower leverage
Best for: income & stability and sleep-well-at-night
NVDA
NVIDIA Corporation
The Growth Play

NVDA carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 65.5%, EPS growth 66.7%, 3Y rev CAGR 100.0%
  • 243.2% 10Y total return vs ISRG's 5.5%
  • PEG 0.27 vs ISRG's 1.99
  • 65.5% revenue growth vs IRBT's -23.4%
Best for: growth exposure and long-term compounding
NVCR
NovoCure Limited
The Healthcare Pick

Among these 5 stocks, NVCR doesn't own a clear edge in any measured category.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthNVDA logoNVDA65.5% revenue growth vs IRBT's -23.4%
ValueNVDA logoNVDABetter valuation composite
Quality / MarginsNVDA logoNVDA55.6% margin vs RR's -249.5%
Stability / SafetyISRG logoISRGBeta 1.00 vs IRBT's 5.31, lower leverage
DividendsNVDA logoNVDA0.0% yield; 2-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)NVDA logoNVDA+83.4% vs IRBT's -98.0%
Efficiency (ROA)NVDA logoNVDA58.1% ROA vs IRBT's -43.3%, ROIC 81.8% vs -38.6%

RR vs IRBT vs ISRG vs NVDA vs NVCR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

RRRichtech Robotics Inc. Class B Common Stock
FY 2025
Service
100.0%$1M
IRBTiRobot Corporation
FY 2024
Reportable Segment
100.0%$682M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
NVDANVIDIA Corporation
FY 2026
Data Center
89.7%$193.7B
Gaming
7.4%$16.0B
Professional Visualization
1.5%$3.2B
Automotive
1.1%$2.3B
OEM And Other
0.3%$619M
NVCRNovoCure Limited

Segment breakdown not available.

RR vs IRBT vs ISRG vs NVDA vs NVCR — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLNVDALAGGINGNVCR

Income & Cash Flow (Last 12 Months)

NVDA leads this category, winning 4 of 6 comparable metrics.

NVDA is the larger business by revenue, generating $215.9B annually — 43756.4x RR's $5M. NVDA is the more profitable business, keeping 55.6% of every revenue dollar as net income compared to RR's -2.5%. On growth, NVDA holds the edge at +73.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricRR logoRRRichtech Robotics…IRBT logoIRBTiRobot CorporationISRG logoISRGIntuitive Surgica…NVDA logoNVDANVIDIA CorporationNVCR logoNVCRNovoCure Limited
RevenueTrailing 12 months$5M$547M$10.6B$215.9B$674M
EBITDAEarnings before interest/tax-$23M-$151M$3.8B$133.2B-$165M
Net IncomeAfter-tax profit-$12M-$209M$3.0B$120.1B-$173M
Free Cash FlowCash after capex-$10M-$107M$2.8B$96.7B-$48M
Gross MarginGross profit ÷ Revenue+55.8%+22.0%+66.3%+71.1%+75.2%
Operating MarginEBIT ÷ Revenue-5.2%-29.5%+30.5%+60.4%-27.2%
Net MarginNet income ÷ Revenue-2.5%-38.2%+28.2%+55.6%-25.7%
FCF MarginFCF ÷ Revenue-2.1%-19.6%+26.8%+44.8%-7.1%
Rev. Growth (YoY)Latest quarter vs prior year-8.8%-24.6%+23.0%+73.2%+12.3%
EPS Growth (YoY)Latest quarter vs prior year+100.0%-195.2%+18.8%+97.8%-100.0%
NVDA leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

NVDA leads this category, winning 4 of 7 comparable metrics.

At 43.9x trailing earnings, NVDA trades at a 23% valuation discount to ISRG's 57.2x P/E. Adjusting for growth (PEG ratio), NVDA offers better value at 0.46x vs ISRG's 2.63x — a lower PEG means you pay less per unit of expected earnings growth.

MetricRR logoRRRichtech Robotics…IRBT logoIRBTiRobot CorporationISRG logoISRGIntuitive Surgica…NVDA logoNVDANVIDIA CorporationNVCR logoNVCRNovoCure Limited
Market CapShares × price$460M$2M$159.8B$5.23T$2.0B
Enterprise ValueMkt cap + debt − cash$267M$95M$156.8B$5.23T$2.2B
Trailing P/EPrice ÷ TTM EPS-20.31x-0.01x57.19x43.92x-14.66x
Forward P/EPrice ÷ next-FY EPS est.43.35x26.00x
PEG RatioP/E ÷ EPS growth rate2.63x0.46x
EV / EBITDAEnterprise value multiple43.28x39.27x
Price / SalesMarket cap ÷ Revenue91.21x0.00x15.88x24.22x3.11x
Price / BookPrice ÷ Book value/share1.19x0.03x9.10x33.43x5.86x
Price / FCFMarket cap ÷ FCF64.18x54.10x
NVDA leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

NVDA leads this category, winning 5 of 9 comparable metrics.

NVDA delivers a 76.3% return on equity — every $100 of shareholder capital generates $76 in annual profit, vs $-113 for IRBT. RR carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRBT's 3.71x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs IRBT's 3/9, reflecting solid financial health.

MetricRR logoRRRichtech Robotics…IRBT logoIRBTiRobot CorporationISRG logoISRGIntuitive Surgica…NVDA logoNVDANVIDIA CorporationNVCR logoNVCRNovoCure Limited
ROE (TTM)Return on equity-3.6%-112.9%+16.9%+76.3%-50.8%
ROA (TTM)Return on assets-3.5%-43.3%+14.8%+58.1%-16.5%
ROICReturn on invested capital-25.7%-38.6%+15.0%+81.8%-16.4%
ROCEReturn on capital employed-11.5%-27.7%+16.5%+97.2%-28.9%
Piotroski ScoreFundamental quality 0–953645
Debt / EquityFinancial leverage0.00x3.71x0.02x0.07x0.85x
Net DebtTotal debt minus cash-$193M$93M-$3.1B$807M$187M
Cash & Equiv.Liquid assets$194M$134M$3.4B$10.6B$103M
Total DebtShort + long-term debt$730,000$227M$303M$11.4B$290M
Interest CoverageEBIT ÷ Interest expense-158.47x-3.36x545.03x-96.80x
NVDA leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

NVDA leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in NVDA five years ago would be worth $150,908 today (with dividends reinvested), compared to $6 for IRBT. Over the past 12 months, NVDA leads with a +83.4% total return vs IRBT's -98.0%. The 3-year compound annual growth rate (CAGR) favors NVDA at 94.7% vs IRBT's -88.8% — a key indicator of consistent wealth creation.

MetricRR logoRRRichtech Robotics…IRBT logoIRBTiRobot CorporationISRG logoISRGIntuitive Surgica…NVDA logoNVDANVIDIA CorporationNVCR logoNVCRNovoCure Limited
YTD ReturnYear-to-date-24.1%-55.0%-19.9%+14.0%+36.4%
1-Year ReturnPast 12 months+28.8%-98.0%-16.4%+83.4%+2.6%
3-Year ReturnCumulative with dividends-49.7%-99.9%+48.5%+638.6%-74.2%
5-Year ReturnCumulative with dividends-49.7%-99.9%+61.7%+1409.1%-90.2%
10-Year ReturnCumulative with dividends-49.7%-99.9%+549.2%+24324.1%+38.5%
CAGR (3Y)Annualised 3-year return-20.5%-88.8%+14.1%+94.7%-36.4%
NVDA leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ISRG and NVDA each lead in 1 of 2 comparable metrics.

ISRG is the less volatile stock with a 1.00 beta — it tends to amplify market swings less than IRBT's 5.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVDA currently trades 98.8% from its 52-week high vs IRBT's 0.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricRR logoRRRichtech Robotics…IRBT logoIRBTiRobot CorporationISRG logoISRGIntuitive Surgica…NVDA logoNVDANVIDIA CorporationNVCR logoNVCRNovoCure Limited
Beta (5Y)Sensitivity to S&P 5004.07x5.31x1.00x1.74x2.15x
52-Week HighHighest price in past year$7.43$6.10$603.88$217.80$20.06
52-Week LowLowest price in past year$1.71$0.04$427.84$115.21$9.82
% of 52W HighCurrent price vs 52-week peak+35.5%+0.9%+74.5%+98.8%+89.2%
RSI (14)Momentum oscillator 0–10058.733.943.663.470.9
Avg Volume (50D)Average daily shares traded8.4M01.8M160.0M1.4M
Evenly matched — ISRG and NVDA each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: RR as "Buy", ISRG as "Buy", NVDA as "Buy", NVCR as "Buy". Consensus price targets imply 127.3% upside for RR (target: $6) vs 28.1% for NVDA (target: $276).

MetricRR logoRRRichtech Robotics…IRBT logoIRBTiRobot CorporationISRG logoISRGIntuitive Surgica…NVDA logoNVDANVIDIA CorporationNVCR logoNVCRNovoCure Limited
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$6.00$622.60$275.74$33.50
# AnalystsCovering analysts2557915
Dividend YieldAnnual dividend ÷ price+0.0%
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS$0.04
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+1.4%+0.8%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

NVDA leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.

Best OverallNVIDIA Corporation (NVDA)Leads 4 of 6 categories
Loading custom metrics...

RR vs IRBT vs ISRG vs NVDA vs NVCR: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is RR or IRBT or ISRG or NVDA or NVCR a better buy right now?

For growth investors, NVIDIA Corporation (NVDA) is the stronger pick with 65.

5% revenue growth year-over-year, versus -23. 4% for iRobot Corporation (IRBT). NVIDIA Corporation (NVDA) offers the better valuation at 43. 9x trailing P/E (26. 0x forward), making it the more compelling value choice. Analysts rate Richtech Robotics Inc. Class B Common Stock (RR) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — RR or IRBT or ISRG or NVDA or NVCR?

On trailing P/E, NVIDIA Corporation (NVDA) is the cheapest at 43.

9x versus Intuitive Surgical, Inc. at 57. 2x. On forward P/E, NVIDIA Corporation is actually cheaper at 26. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NVIDIA Corporation wins at 0. 27x versus Intuitive Surgical, Inc. 's 1. 99x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — RR or IRBT or ISRG or NVDA or NVCR?

Over the past 5 years, NVIDIA Corporation (NVDA) delivered a total return of +1409%, compared to -99.

9% for iRobot Corporation (IRBT). Over 10 years, the gap is even starker: NVDA returned +243. 2% versus IRBT's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — RR or IRBT or ISRG or NVDA or NVCR?

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 00β versus iRobot Corporation's 5. 31β — meaning IRBT is approximately 432% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Richtech Robotics Inc. Class B Common Stock (RR) carries a lower debt/equity ratio of 0% versus 4% for iRobot Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — RR or IRBT or ISRG or NVDA or NVCR?

By revenue growth (latest reported year), NVIDIA Corporation (NVDA) is pulling ahead at 65.

5% versus -23. 4% for iRobot Corporation (IRBT). On earnings-per-share growth, the picture is similar: NVIDIA Corporation grew EPS 66. 7% year-over-year, compared to -8. 3% for Richtech Robotics Inc. Class B Common Stock. Over a 3-year CAGR, NVDA leads at 100. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — RR or IRBT or ISRG or NVDA or NVCR?

NVIDIA Corporation (NVDA) is the more profitable company, earning 55.

6% net margin versus -312. 3% for Richtech Robotics Inc. Class B Common Stock — meaning it keeps 55. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVDA leads at 60. 4% versus -355. 7% for RR. At the gross margin level — before operating expenses — NVCR leads at 74. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is RR or IRBT or ISRG or NVDA or NVCR more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, NVIDIA Corporation (NVDA) is the more undervalued stock at a PEG of 0. 27x versus Intuitive Surgical, Inc. 's 1. 99x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NVIDIA Corporation (NVDA) trades at 26. 0x forward P/E versus 43. 3x for Intuitive Surgical, Inc. — 17. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RR: 127. 3% to $6. 00.

08

Which pays a better dividend — RR or IRBT or ISRG or NVDA or NVCR?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is RR or IRBT or ISRG or NVDA or NVCR better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), +549. 2% 10Y return). iRobot Corporation (IRBT) carries a higher beta of 5. 31 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +549. 2%, IRBT: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between RR and IRBT and ISRG and NVDA and NVCR?

These companies operate in different sectors (RR (Industrials) and IRBT (Consumer Cyclical) and ISRG (Healthcare) and NVDA (Technology) and NVCR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: RR is a small-cap high-growth stock; IRBT is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock; NVDA is a mega-cap high-growth stock; NVCR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

RR

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
  • Gross Margin > 33%
Run This Screen
Stocks Like

IRBT

Quality Business

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Gross Margin > 13%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

NVDA

High-Growth Quality Leader

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 36%
  • Net Margin > 33%
Run This Screen
Stocks Like

NVCR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Gross Margin > 45%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform RR and IRBT and ISRG and NVDA and NVCR on the metrics below

Revenue Growth>
%
(RR: -8.8% · IRBT: -24.6%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.